•  
• Tweet
•  
•  
•        Print
•  
•        Email
•  
•         Track Keywords

Dr. Ewan Kirk

The announcement is in recognition of Dr. Killeya’s and Dr.Diamond’s contribution to Cantab’s business success and growth. Genia has lead the Investor Relations team that has overseen Cantab’s assets increase fivefold to USD 5,3 billion since 2011.

Matthew’s primary focus is on investment strategy development, having contributed strategies in all three of the clusters within the portfolio (momentum, value and short term).

Commenting on the move, Dr. Ewan Kirk said: “Our investors know that we take both our investment models and investor relations immensely seriously. Both Genia and Matthew have contributed significantly to these respective functions, as well as the overall development of Cantab. As a result we are truly pleased they have accepted our offer to join the partnership.”

Press release

Cantab Capital Partners LLP is a $5.3 billion total assets under management systematic global macro manager based in Cambridge, England. Cantab was founded in 2006 by Dr Ewan Kirk (ex-Goldman Sachs), Erich Schlaikjer (ex-Goldman Sachs) and Chris Pugh (ex-KBC). Dr Tom Howat became a Partner in 2011. The investor base is 60% institutional, 35% fund of funds, and 5% family offices/high net worth individuals. www.cantabcapital.com

Dr Genia Diamond – Head of Business Development
Genia leads the team responsible for all investor-related activities helping to further expand the firm’s reputation and place amongst investors globally.

Genia joined Cantab from OMAM UK and prior to that she was at Solent Capital and BlueCrest Capital. She started her career in asset management as a senior HF researcher at PAAMCO. Genia has a PhD in linguistics from the Moscow State University, an MBA from Erasmus University in the Netherlands and achieved an MA (honours) in Linguistics & Culture Studies from the Moscow State University.

Dr Matthew Killeya – Senior Scientist
Matthew works on all aspects of programme and portfolio construction and has driven developments in these areas, including contributing several new strategies to the portfolio.

More recently Matt’s focus has been on short term execution algorithms and strategies to trade options as a natural diversifier to the futures strategies.

Previously Matt was a senior managing researcher at Winton Capital Management for five years. Matt has a PhD in Bayesian statistics from Durham University. Prior to that, Matt obtained a first class Master of Mathematics degree, also from Durham University.

Bg